These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 366366)
21. The systemic use of procaine in the treatment of the elderly: a review. Ostfeld A; Smith CM; Stotsky BA J Am Geriatr Soc; 1977 Jan; 25(1):1-19. PubMed ID: 12204 [TBL] [Abstract][Full Text] [Related]
22. [Preliminary results of clinical trials of a new anti-aging preparation]. Bottecchia G; Pesaro F; Salmeri G G Gerontol; 1969 Aug; 17(8):817-22. PubMed ID: 5371745 [No Abstract] [Full Text] [Related]
23. Procaine. Will it keep you younger longer? Thomas R Med J Aust; 1983 Jun; 1(12):543-5. PubMed ID: 6855656 [No Abstract] [Full Text] [Related]
24. [Electroencephalographic findings in a group of aged subjects treated with potentiated gerovital-H3]. Aslan A; Buşilă V; Sacerdoţeanu F Fiziol Norm Patol; 1968; 14(3):263-70. PubMed ID: 5686658 [No Abstract] [Full Text] [Related]
25. [Therapy with Gerovital H3 in ambulatory conditions]. Creţeanu C; Hurjui J; Bejan V; Duda R; Albu D Rev Med Chir Soc Med Nat Iasi; 1971; 75(1):169-74. PubMed ID: 5552552 [No Abstract] [Full Text] [Related]
27. The effects of procaine/haematoporphyrin on age-related decline: a double-blind trial. Hall MR; Briggs RS; MacLennan WJ; Marcer D; Robinson MJ; Everett FM Age Ageing; 1983 Nov; 12(4):302-8. PubMed ID: 6362368 [TBL] [Abstract][Full Text] [Related]
28. [Successes in novocain therapy in the control of premature ageing (author's transl)]. Zdichynec B Z Alternsforsch; 1977; 32(3):267-9. PubMed ID: 337694 [TBL] [Abstract][Full Text] [Related]
29. [Treatment of presenile and senile complaints with an oral procaine-hematoporphyrin preparation]. Carca AS; Dutren AM Hippokrates; 1968 Oct; 39(19):751-5. PubMed ID: 5730936 [No Abstract] [Full Text] [Related]
30. [Use of procaine chlorhydrate in arteriosclerotic patients and mental functions]. Colucci D'Amato F; Rogliani G; Feis P Acta Neurol (Napoli); 1975; 30(5):510-4. PubMed ID: 779410 [No Abstract] [Full Text] [Related]
32. [Considerations on the influence of treatment with Gerovital H3 (lozenges) on working capacity of active persons over 45 years of age]. Untea G; Bercu G G Gerontol; 1969 Aug; 17(8):795-9. PubMed ID: 5371742 [No Abstract] [Full Text] [Related]
33. An overview of pharmacologic treatment of cognitive decline in the aged. Reisberg B; Ferris SH; Gershon S Am J Psychiatry; 1981 May; 138(5):593-600. PubMed ID: 7015883 [TBL] [Abstract][Full Text] [Related]
34. [Mental effects of Wallerox therapy in the aged]. Thomae H Med Klin; 1970 Jun; 65(23):1132-4. PubMed ID: 5000216 [No Abstract] [Full Text] [Related]
38. [Studies of peripheral circulation with the postural oscillometric method in a group of aged persons treated with potentiated Gerovital H]. Aslan A; Vrăbiescu A; Buşilă V Fiziol Norm Patol; 1967; 13(6):561-6. PubMed ID: 5594206 [No Abstract] [Full Text] [Related]
39. Treatment of elderly mental patients with trimeprazine. (Problems of psychopharmacology). Brzezicki E; Ryn Z Mater Med Pol; 1971; 3(2):32-4. PubMed ID: 5162161 [No Abstract] [Full Text] [Related]